CAT No: CP06204
CAS No:201418-83-9
Synonyms/Alias:201418-83-9;(S)-2-((tert-Butoxycarbonyl)amino)-6-ureidohexanoic acid;BOC-HCI-OH;Boc-L-homocitruline;Boc-Lys(carbamoyl)-OH;L-Lysine, N6-(aminocarbonyl)-N2-[(1,1-dimethylethoxy)carbonyl]-;(2S)-6-(carbamoylamino)-2-[(2-methylpropan-2-yl)oxycarbonylamino]hexanoic acid;Boc-Homocit-OH;Boc-L-HomoCit-OH;C12H23N3O5;Boc-L-Hcit-OH;N~2~-(tert-Butoxycarbonyl)-N~6~-carbamoyl-L-lysine;(S)-2-((tert-Butoxycarbonyl)amino)-6-ureidohexanoicacid;DTXSID30426774;MFCD00151903;AKOS016843071;(S)-2-Boc-amino-6-ureidohexanoic acid;CS-0449637;G84326;N2-(tert-Butoxycarbonyl)-N6-carbamoyl-L-lysine;(S)-2-(tert-butoxycarbonylamino)-6-ureidohexanoic acid;(2S)-2-[(TERT-BUTOXYCARBONYL)AMINO]-6-(CARBAMOYLAMINO)HEXANOIC ACID;
4. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
5. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.